/EG
EG Stock - Everest Re Group, Ltd.
Financial Services|Insurance - ReinsuranceNYSE
$331.31-0.36%
$1.21 (-0.36%) • Dec 19
71
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.50
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).82
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+15.9%upside
Target: $383.99
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for EG
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$328.00 – $334.62
TARGET (TP)$384.00
STOP LOSS$304.81
RISK/REWARD1:2.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.38
52W High$373.23
52W Low$302.44
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $17.08B | $14.46B | $11.98B | $11.33B | $9.60B |
| Gross Profit | $2.47B | $3.08B | $1.36B | $1.73B | $1.17B |
| Gross Margin | 14.5% | 21.3% | 11.3% | 15.3% | 12.2% |
| Operating Income | $1.50B | $2.15B | $588.00M | $1.54B | $586.00M |
| Net Income | $1.37B | $2.52B | $597.00M | $1.38B | $514.00M |
| Net Margin | 8.0% | 17.4% | 5.0% | 12.2% | 5.4% |
| EPS | $31.78 | $60.19 | $15.10 | $34.66 | $12.81 |
Company Overview
Everest Group, Ltd., through its subsidiaries, provides reinsurance and insurance products in the United States, Bermuda, and internationally. The company operates through Reinsurance Operations and Insurance Operations segments. The Reinsurance Operations segment writes property and casualty reinsurance; and specialty lines of business through reinsurance brokers, as well as directly with ceding companies in the United States, Bermuda, Ireland, Canada, Singapore, Switzerland, and the United Kingdom. The Insurance Operations segment writes property and casualty insurance directly, as well as through brokers, surplus lines brokers, and general agents in the United States, Bermuda, Canada, Europe, South America, France, Germany, Spain, Canada, Chile, the United Kingdom, Ireland, and the Netherlands. The company also provides treaty and facultative reinsurance products; admitted and non-admitted insurance products; and property and casualty reinsurance and insurance coverages, including marine, aviation, surety, errors and omissions liability, directors' and officers' liability, medical malpractice, mortgage reinsurance, other specialty lines, accident and health, and workers' compensation products. In addition, it offers commercial property and casualty insurance products through wholesale and retail brokers, surplus lines brokers, and program administrators. The company was formerly known as Everest Re Group, Ltd. and changed its name to Everest Group, Ltd. in July 2023. The company was founded in 1973 and is headquartered in Hamilton, Bermuda.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
5
38%
Hold / Neutral
7
54%
Sell / Underperform
1
8%
Analyst Consensus🔴 Bearish
5 Bullish8 Neutral/Bearish
Price Targets
$402
Average Target
↑ 21.4% Upside
Now
$287
Low
$402
Average
$527
High
Based on 16 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| December 16th 2025 | Mizuho | Initiation | Neutral | - |
| October 29th 2025 | Wolfe Research | Upgrade | Peer Perform | - |
| September 22nd 2025 | Raymond James | Downgrade | Outperform | $375 |
| September 16th 2025 | Wolfe Research | Initiation | Underperform | $287 |
| August 13th 2025 | Cantor Fitzgerald | Initiation | Neutral | $368 |
| August 13th 2025 | Citigroup | Initiation | Neutral | $362 |
| June 20th 2025 | Janney | Initiation | Buy | $425 |
| April 11th 2025 | Jefferies | Upgrade | Buy | $415 |
| February 5th 2025 | Morgan Stanley | Downgrade | Equal Weight | $340← $425 |
| January 30th 2025 | BMO Capital Markets | Downgrade | Market Perform | $375← $453 |
| January 10th 2025 | BMO Capital Markets | Upgrade | Outperform | $453← $372 |
| November 26th 2024 | Jefferies | Downgrade | Hold | $429← $420 |
| September 5th 2024 | Barclays | Initiation | Overweight | $527 |
| February 12th 2024 | Citigroup | Downgrade | Neutral | $375← $452 |
| February 9th 2024 | Wells Fargo | Downgrade | Equal Weight | $402← $484 |
Earnings History & Surprises
EGBeat Rate
50%
Last 16 quarters
Avg Surprise
-24.1%
EPS vs Estimate
Beats / Misses
8/8
Last 12 quarters
Latest EPS
$7.54
Q4 2025
EPS Surprise History
Q1 24
+72.1%
$25.18vs$14.63
Q2 24
+1.9%
$16.32vs$16.01
Q3 24
+1.6%
$16.85vs$16.59
Q4 24
+22.8%
$14.62vs$11.91
Q1 25
-258.0%
$-18.39vs$11.64
Q2 25
-15.0%
$6.45vs$7.59
Q3 25
+14.7%
$17.36vs$15.14
Q4 25
-43.7%
$7.54vs$13.39
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 2, 2026 | $12.59 | — | — | — |
Q4 2025 | Oct 27, 2025 | $13.39 | $7.54 | -43.7% | ✗ MISS |
Q3 2025 | Jul 30, 2025 | $15.14 | $17.36 | +14.7% | ✓ BEAT |
Q2 2025 | Apr 30, 2025 | $7.59 | $6.45 | -15.0% | ✗ MISS |
Q1 2025 | Feb 3, 2025 | $11.64 | $-18.39 | -258.0% | ✗ MISS |
Q4 2024 | Oct 30, 2024 | $11.91 | $14.62 | +22.8% | ✓ BEAT |
Q3 2024 | Jul 31, 2024 | $16.59 | $16.85 | +1.6% | ✓ BEAT |
Q2 2024 | Apr 29, 2024 | $16.01 | $16.32 | +1.9% | ✓ BEAT |
Q1 2024 | Feb 7, 2024 | $14.63 | $25.18 | +72.1% | ✓ BEAT |
Q4 2023 | Oct 25, 2023 | $10.60 | $14.14 | +33.4% | ✓ BEAT |
Q3 2023 | Jul 26, 2023 | $11.64 | $15.21 | +30.7% | ✓ BEAT |
Q2 2023 | May 2, 2023 | $12.51 | $11.31 | -9.6% | ✗ MISS |
Q1 2023 | Feb 8, 2023 | $9.29 | $12.21 | +31.4% | ✓ BEAT |
Q3 2022 | Sep 30, 2022 | $-4.95 | $-8.22 | -66.2% | ✗ MISS |
Q2 2022 | Jun 30, 2022 | $8.06 | $3.11 | -61.4% | ✗ MISS |
Q1 2022 | Mar 31, 2022 | $9.42 | $7.67 | -18.6% | ✗ MISS |
Q4 2021 | Dec 31, 2021 | — | $10.99 | — | — |
Q3 2021 | Sep 30, 2021 | $8.92 | $-1.87 | -121.0% | ✗ MISS |
Q2 2021 | Jun 30, 2021 | — | $17.19 | — | — |
Q1 2021 | Mar 31, 2021 | — | $8.63 | — | — |
Latest News
Mizuho Initiates Coverage On Everest Group with Neutral Rating, Announces Price Target of $359
➖ NeutralBenzinga•Dec 16, 2025, 01:13 PM
TD Cowen Maintains Hold on Everest Group, Lowers Price Target to $365
➖ NeutralBenzinga•Dec 15, 2025, 04:31 PM
Everest Group Appoints Elias Habayeb Group CFO, Effective Around May 1, 2026, Succeeding Mark Kociancic
➖ NeutralBenzinga•Nov 20, 2025, 09:17 PM
Barclays Maintains Overweight on Everest Group, Lowers Price Target to $365
📈 PositiveBenzinga•Nov 3, 2025, 02:35 PM•Also:
Keefe, Bruyette & Woods Maintains Outperform on Everest Group, Lowers Price Target to $400
➖ NeutralBenzinga•Oct 30, 2025, 02:03 PM
Wells Fargo Maintains Equal-Weight on Everest Group, Lowers Price Target to $343
➖ NeutralBenzinga•Oct 29, 2025, 02:12 PM
Wolfe Research Upgrades Everest Group to Peer Perform
📈 PositiveBenzinga•Oct 29, 2025, 12:25 PM
Barclays Maintains Overweight on Everest Group, Lowers Price Target to $425
➖ NeutralBenzinga•Oct 28, 2025, 01:11 PM•Also:
Everest Group shares are trading lower after the company reported Q3 financial results below estimates.
📉 NegativeBenzinga•Oct 27, 2025, 08:43 PM
Everest Group Q3 Adj. EPS $7.54 Misses $14.39 Estimate, Sales $3.855B Miss $4.034B Estimate
📉 NegativeBenzinga•Oct 27, 2025, 08:29 PM
Everest Group Enters $1.2B Adverse Development Reinsurance Agreement With Stone Ridge Affiliate Covering North American Insurance Reserves Through 2024
📉 NegativeBenzinga•Oct 27, 2025, 08:25 PM
Barclays Maintains Overweight on Everest Group, Raises Price Target to $430
📈 PositiveBenzinga•Oct 8, 2025, 03:26 PM•Also:
Wells Fargo Maintains Equal-Weight on Everest Group, Raises Price Target to $383
📈 PositiveBenzinga•Oct 8, 2025, 02:22 PM
Evercore ISI Group Maintains In-Line on Everest Group, Raises Price Target to $384
📈 PositiveBenzinga•Oct 1, 2025, 03:07 PM
Raymond James Downgrades Everest Group to Outperform, Lowers Price Target to $375
📉 NegativeBenzinga•Sep 22, 2025, 04:25 PM
Everest Group shares are trading lower after Wolfe Research initiated coverage on the stock with an Underperform rating and announced a $287 price target.
📉 NegativeBenzinga•Sep 16, 2025, 02:26 PM
Wolfe Research Initiates Coverage On Everest Group with Underperform Rating, Announces Price Target of $287
📉 NegativeBenzinga•Sep 16, 2025, 11:57 AM
Frequently Asked Questions about EG
What is EG's current stock price?
Everest Re Group, Ltd. (EG) is currently trading at $331.31 per share. The stock has moved -0.36% today.
What is the analyst price target for EG?
The average analyst price target for EG is $384.00, based on 1 analyst.
What sector is Everest Re Group, Ltd. in?
Everest Re Group, Ltd. operates in the Financial Services sector, specifically within the Insurance - Reinsurance industry. The company is traded on the NYSE exchange.
What is EG's market cap?
Everest Re Group, Ltd. has a market capitalization of $13.90 billion, making it a large-cap company.
Does EG pay dividends?
No, Everest Re Group, Ltd. does not currently pay a dividend to shareholders.
Similar Stocks
Financial Services SectorBCH
Banco de Chile
$37.69
Mkt Cap: $19.0B
BNT
Brookfield Wealth Solutions Ltd.
$45.22
Mkt Cap: $13.9B
CNA
CNA Financial Corporation
$47.43
Mkt Cap: $12.8B
EQH
Equitable Holdings, Inc.
$48.02
Mkt Cap: $14.6B
ERIE
Erie Indemnity Company
$283.82
Mkt Cap: $13.1B
FNF
Fidelity National Financial, Inc.
$55.83
Mkt Cap: $15.1B
MET
MetLife, Inc.
$81.57
Mkt Cap: $53.7B
RGA
Reinsurance Group of America, Incorporated
$205.70
Mkt Cap: $13.5B
RNR
RenaissanceRe Holdings Ltd.
$278.52
Mkt Cap: $12.8B
Explore stocks similar to EG for comparison